4.5 Article

Immunotoxicity of aflatoxin B1 in rats:: Effects on lymphocytes and the inflammatory response in a chronic intermittent dosing study

期刊

TOXICOLOGICAL SCIENCES
卷 73, 期 2, 页码 362-377

出版社

OXFORD UNIV PRESS
DOI: 10.1093/toxsci/kfg074

关键词

aflatoxin B-1; immunotoxicity; inflammatory response; intermittent dosing

向作者/读者索取更多资源

We investigated the effects of aflatoxin B-1 (AFB(1)) on isolated splenic lymphocytes and the histo-morphologic changes in the spleens and liver of Fisher-344 male rats. Weaned animals were fed chow diets that contained 0, 0.01, 0.04, 0.4, or 1.6 ppm AFB(1), using an intermittent dosing regimen (4 weeks on and 4 weeks off AFB(1)), for 40 weeks. An additional group of animals was fed the 1.6 ppm AFB(1) diet continuously. The intermittent dosing regimen was designed to evaluate effects of cumulative dose and exposure for risk assessment comparisons. The percentages of T and B cells were affected as shown by flow cytometric analysis after the dosing cycles. The observed changes appeared to reverse or compensate to some extent after the off cycles. Lymphocytes were stimulated in culture for analysis of the production of IL-2, IL-1, and IL-6. Significantly increased production of IL-1 and IL-6 was seen in the second dosing cycle (12 weeks) and the second off cycle (16 weeks) at the higher doses. Inflammatory infiltrates were seen in the liver after eight weeks of continuous and intermittent dosing and were increased in size and number at 12 weeks in both 1.6 ppm dose groups correlating with the peak production of Il-1 and IL-6. We concluded that AFB(1) effects on the immune system can be either stimulatory or suppressive dependent on a critical exposure window of dose and time. Immune cells in spleen such as T-lymphocytes and macrophages, both important mediators of inflammatory responses to tissue damage, were affected differently in the continuous and intermittent exposures to AFB(1).

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据